Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 106, Issue 4, Pages 579-587Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI9075
Keywords
-
Categories
Funding
- NCRR NIH HHS [M01 RR000080, RR00080] Funding Source: Medline
- NHLBI NIH HHS [HL29582, P01 HL029582] Funding Source: Medline
Ask authors/readers for more resources
Thrombin stimulates the expression of multiple genes in endothelial cells (ECs), but the trans-acting factors responsible for this induction remain undefined. We have previously described a thrombin-inducible nuclear factor (TINF), which binds to an element in the PDGF B promoter and is responsible for the thrombin inducibility of this gene. Inactive cytoplasmic TINF is rapidly activated and translocated to nuclei of ECs upon stimulation with thrombin. We have now purified TINF from thrombin-treated ECs. Amino acid sequencing revealed it to be a member of the Y-box protein family, and the sole Y-box protein-encoding cDNA we detected in human or bovine ECs corresponded to DNA-binding protein B (dbpB). DbpB translocated to the nucleus after thrombin stimulation of ECs as shown by FAGS analysis of nuclei from ECs expressing GFP-dbpB fusion proteins. During thrombin activation, dbpB mas found to be cleaved, yielding a 30-kDa NH2-terminal fragment that recognized the thrombin-response element sequence, but not the Y-box consensus sequence. Preincubation of ECs with protein tyrosine phosphatase inhibitors completely blocked dbpB activation by thrombin and blocked induction of endogenous PDGF B-chain mRNA and promoter activation by thrombin. Y-box proteins are known to act constitutively to regulate the expression of several genes. Activation of this class of transcription factors in response to thrombin or any other agonist represents a novel signaling pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available